Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.165 USD | +0.10% | +1.28% | -42.66% |
05-02 | Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q1 Revenue $50.3M, vs. Street Est of $47.1M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.66% | 736M | |
+9.70% | 106B | |
+1.79% | 104B | |
+6.72% | 23.25B | |
-13.40% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-11.05% | 16.99B | |
+7.82% | 14.26B | |
+40.32% | 12.76B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- RBC Cuts Price Target on Aurinia Pharmaceuticals to $18 From $22, Citing Potential Scenarios for '036 Patent; Outperform, Speculative Risk Kept